Word

DEGEVMA

Status

Pending

Status Code

616

Status Date

Monday, July 17, 2023

Serial Number

97636862

Mark Type

4000

Filing Date

Tuesday, October 18, 2022

Trademark Owner History

TEVA PHARMACEUTICALS USA, Inc.

Classifications

5 Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

Trademark Events

Jul 18, 2023

Notice Of Revival - E-Mailed

Jul 17, 2023

Petition To Revive-Granted

Jul 17, 2023

Teas Petition To Revive Received

Jul 16, 2023

Abandonment Notice Mailed - Failure To Respond

Jul 16, 2023

Abandonment - Failure To Respond Or Late Response

Mar 29, 2023

Notification Of Non-Final Action E-Mailed

Mar 29, 2023

Non-Final Action E-Mailed

Mar 29, 2023

Non-Final Action Written

Mar 28, 2023

Previous Allowance Count Withdrawn

Mar 28, 2023

Approved For Pub - Principal Register

Mar 28, 2023

Assigned To Examiner

Nov 2, 2022

New Application Office Supplied Data Entered

Oct 21, 2022

New Application Entered